393 related articles for article (PubMed ID: 19033012)
1. Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension.
Napoli C; Bruzzese G; Ignarro LJ; Crimi E; de Nigris F; Williams-Ignarro S; Libardi S; Sommese L; Fiorito C; Mancini FP; Cacciatore F; Liguori A
Am Heart J; 2008 Dec; 156(6):1154.e1-8. PubMed ID: 19033012
[TBL] [Abstract][Full Text] [Related]
2. Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension.
Napoli C; Sica V; de Nigris F; Pignalosa O; Condorelli M; Ignarro LJ; Liguori A
Am Heart J; 2004 Jul; 148(1):e5. PubMed ID: 15215814
[TBL] [Abstract][Full Text] [Related]
3. Effects of ACE inhibition on circulating endothelial progenitor cells, vascular damage, and oxidative stress in hypertensive patients.
Cacciatore F; Bruzzese G; Vitale DF; Liguori A; de Nigris F; Fiorito C; Infante T; Donatelli F; Minucci PB; Ignarro LJ; Napoli C
Eur J Clin Pharmacol; 2011 Sep; 67(9):877-83. PubMed ID: 21445638
[TBL] [Abstract][Full Text] [Related]
4. Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials.
Wang JG; Staessen JA; Li Y; Van Bortel LM; Nawrot T; Fagard R; Messerli FH; Safar M
Stroke; 2006 Jul; 37(7):1933-40. PubMed ID: 16763185
[TBL] [Abstract][Full Text] [Related]
5. A one-year study of the antiatherosclerotic effect of the angiotensin-II receptor blocker losartan in hypertensive patients. A comparison with angiotension-converting enzyme inhibitors.
Sonoda M; Aoyagi T; Takenaka K; Uno K; Nagai R
Int Heart J; 2008 Jan; 49(1):95-103. PubMed ID: 18360068
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen Sulphide Release via the Angiotensin Converting Enzyme Inhibitor Zofenopril Prevents Intimal Hyperplasia in Human Vein Segments and in a Mouse Model of Carotid Artery Stenosis.
Macabrey D; Deslarzes-Dubuis C; Longchamp A; Lambelet M; Ozaki CK; Corpataux JM; Allagnat F; Déglise S
Eur J Vasc Endovasc Surg; 2022 Feb; 63(2):336-346. PubMed ID: 34916111
[TBL] [Abstract][Full Text] [Related]
7. [Local pulse pressure and regression of arterial wall hypertrophy during antihypertensive treatment. CELIMENE study. The Celiprolol Intima-Media Enalapril Efficacy study].
Boutouyrie P; Bussy C; Tropeano AI; Hayoz D; Hengstler J; Dartois N; Laloux B; Brunner H; Laurent S
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):911-5. PubMed ID: 10989729
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibition with enalapril slows progressive intima-media thickening of the common carotid artery in patients with non-insulin-dependent diabetes mellitus.
Hosomi N; Mizushige K; Ohyama H; Takahashi T; Kitadai M; Hatanaka Y; Matsuo H; Kohno M; Koziol JA
Stroke; 2001 Jul; 32(7):1539-45. PubMed ID: 11441198
[TBL] [Abstract][Full Text] [Related]
9. Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice.
de Nigris F; D'Armiento FP; Somma P; Casini A; Andreini I; Sarlo F; Mansueto G; De Rosa G; Bonaduce D; Condorelli M; Napoli C
Int J Cardiol; 2001 Dec; 81(2-3):107-15; discusssion 115-6. PubMed ID: 11744122
[TBL] [Abstract][Full Text] [Related]
10. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients.
Pasini AF; Garbin U; Nava MC; Stranieri C; Pellegrini M; Boccioletti V; Luchetta ML; Fabrizzi P; Lo Cascio V; Cominacini L
Am J Hypertens; 2007 Apr; 20(4):443-50. PubMed ID: 17386354
[TBL] [Abstract][Full Text] [Related]
11. Candesartan decreases carotid intima-media thickness by enhancing nitric oxide and decreasing oxidative stress in patients with hypertension.
Ono H; Minatoguchi S; Watanabe K; Yamada Y; Mizukusa T; Kawasaki H; Takahashi H; Uno T; Tsukamoto T; Hiei K; Fujiwara H
Hypertens Res; 2008 Feb; 31(2):271-9. PubMed ID: 18360047
[TBL] [Abstract][Full Text] [Related]
12. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
[TBL] [Abstract][Full Text] [Related]
13. Effects of amlodipine and lisinopril on intima-media thickness in previously untreated, elderly hypertensive patients (the ELVERA trial).
Terpstra WF; May JF; Smit AJ; Graeff PA; Meyboom-de Jong B; Crijns HJ
J Hypertens; 2004 Jul; 22(7):1309-16. PubMed ID: 15201546
[TBL] [Abstract][Full Text] [Related]
14. Vascular wall thickness in hypertension: the Perindopril Regression of Vascular Thickening European Community Trial: PROTECT.
Stumpe KO; Ludwig M; Heagerty AM; Kolloch RE; Mancia G; Safar M; Zanchetti A
Am J Cardiol; 1995 Nov; 76(15):50E-54E. PubMed ID: 7484890
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of the initial and long-term antihypertensive efficacy of zofenopril compared with enalapril in mild to moderate hypertension.
Mallion JM
Blood Press Suppl; 2007 Oct; 2():13-8. PubMed ID: 18046974
[TBL] [Abstract][Full Text] [Related]
16. The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness.
Zanchetti A; Rosei EA; Dal Palù C; Leonetti G; Magnani B; Pessina A
J Hypertens; 1998 Nov; 16(11):1667-76. PubMed ID: 9856368
[TBL] [Abstract][Full Text] [Related]
17. [Carotid intima-media thickness measured by ultrasonography: effect of different pharmacotherapies on atherosclerosis progression].
Csiba L
Orv Hetil; 2005 Jun; 146(23):1239-44. PubMed ID: 15988918
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers.
Silva PS; Fontana V; Palei ACT; Sertório JTC; Biagi C; Tanus-Santos JE
Eur J Clin Pharmacol; 2011 Apr; 67(4):365-370. PubMed ID: 21305271
[TBL] [Abstract][Full Text] [Related]
19. Cilostazol reduces the progression of carotid intima-media thickness without increasing the risk of bleeding in patients with acute coronary syndrome during a 2-year follow-up.
Ahn CM; Hong SJ; Park JH; Kim JS; Lim DS
Heart Vessels; 2011 Sep; 26(5):502-10. PubMed ID: 21153029
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of doxazosin and atenolol on target organ damage in adults with type 2 diabetes mellitus and hypertension in the CARDHIAC study: a 9-month, prospective, randomized, open-label, blinded-evaluation trial.
Barrios V; Escobar C; Tomás JP; Calderon A; Echarri R
Clin Ther; 2008 Jan; 30(1):98-107. PubMed ID: 18343246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
